Byers Capital

Venture Capital

Investment firm founded by Brook Byers, co-founder of Kleiner Perkins. Focuses on life sciences and technology investments.

Profile

Headquarters
San Francisco, US
Investments
2
Companies
2

Capital

Total Deployed
$500M
Lead Rounds
0

Portfolio

2 companies
Freenome $1.3B
Private South San Francisco, California, United States

Biotech company developing AI-powered multiomics blood tests for early cancer detection. Its platform analyzes cell-free DNA, methylation patterns, and protein biomarkers from routine blood draws to screen for cancers in their earliest stages. Lead product SimpleScreen targets FDA approval for colorectal cancer screening.
Benchling $412M
Private San Francisco, US

Benchling is a cloud-based life sciences R&D platform that helps biotech and pharmaceutical companies manage experiments, track data, and accelerate research and development. The platform replaces physical lab notebooks and spreadsheets with collaborative, AI-ready digital tools used by over 1,200 customers worldwide.

Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.